DC
TTPH

Deere & Company’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Deere & Company’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-660
Closed -$524K – 1098
2014
Q4 		$524K Buy
+660
New +$355K 0.03% 587

Other funds holding TTPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deere & Company's TTPH Position: Q1 2015 in Review

Deere & Company sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2015, closing a stake of 660 shares — an estimated $524K sold.

Deere & Company first reported a position in TTPH in Q4 2014 and held it in 1 quarter. The position peaked at $524K in Q4 2014. 130 funds tracked by Wall St. Rank hold TTPH as of Q1 2015.

  • Deere & Company reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Deere & Company sold 660 Tetraphase Pharmaceuticals, Inc. shares in Q1 2015, an estimated $524K.
  • Deere & Company first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2014 and held it in 1 quarter.
  • Deere & Company's Tetraphase Pharmaceuticals, Inc. position peaked at $524K in Q4 2014.
  • 130 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2015.

Based on Deere & Company's 13F filing for Q1 2015, filed 13 May 2015.